Inmunología Tumoral

Publicaciones

  • 28/07/2021

    Science Advances

    Regulation of telomere homeostasis and genomic stability in cancer by N 6-adenosine methylation (m 6 A)

    Ji Hoon Lee, Juyeong Hong, Zhao Zhang, Bárbara de la Peña Avalos, Cecilia J Proietti, Agustina Roldán Deamicis, Pablo Guzmán G, Hung-Ming Lam, Jose Garcia, Martine P Roudier, Anthony E Sisk, Richard De La Rosa, Kevin Vu, Mei Yang, Yiji Liao, Jessica Scheirer, Douglas Pechacek, Pooja Yadav, Manjeet K Rao, Siyuan Zheng, Teresa L Johnson-Pais, Robin J Leach, Patricia V Elizalde, Eloïse Dray, Kexin Xu

  • Annals of the New York Academy of Sciences

    01/04/2021

    Annals of the New York Academy of Sciences

    Frontiers in cancer immunotherapy-a symposium report

    Jennifer Cable, Benjamin Greenbaum, Dana Pe’er, Catherine M Bollard, Sofia Bruni, Matthew E Griffin, James P Allison, Catherine J Wu, Sumit K Subudhi, Elaine R Mardis, Renier Brentjens, Jeffry A Sosman, Saso Cemerski, Anastasia-Maria Zavitsanou, Theresa Proia, Mikala Egeblad, Garry Nolan, Sangeeta Goswami, Stefani Spranger, Crystal L Mackall

  • Cells

    02/02/2021

    Cancers (Basel)

    Harnessing Tumor Necrosis Factor Alpha to Achieve Effective Cancer Immunotherapy

    María Florencia Mercogliano, Sofía Bruni, Florencia Mauro, Patricia Virginia Elizalde, Roxana Schillaci

  • 01/10/2020

    Hormones and Cancer

    Nuclear PDCD4 Expression Defines a Subset of Luminal B-Like Breast Cancers With Good Prognosis

    Santiago Madera, María F Chervo, Violeta A Chiauzzi, Matías G Pereyra, Leandro Venturutti, Franco Izzo, Agustina Roldán Deamicis, Pablo Guzman, Agustina Dupont, Juan Carlos Roa, Mauro E Cenciarini, Sabrina Barchuk, Silvina Figurelli, Daniel Lopez Della Vecchia, Claudio Levit, Gabriel Lebersztein, Fabiana Anfuso, Teresa Castiglioni, Eduardo Cortese, Sandra Ares, Ernesto Gil Deza, Felipe G Gercovich, Cecilia J Proietti, Roxana Schillaci, Rosalía I Cordo Russo, Patricia V Elizalde

  • 01/09/2020

    Oncogene

    Canonical ErbB-2 isoform and ErbB-2 variant c located in the nucleus drive triple negative breast cancer growth

    María F Chervo, Rosalía I Cordo Russo, Ezequiel Petrillo, Franco Izzo, Mara De Martino, Nicolás Bellora, Mauro E Cenciarini, Violeta A Chiauzzi, Lucía Santa María de la Parra, Matías G Pereyra, Leandro N Güttlein, Osvaldo L Podhajcer, José L Daniotti, Agustina Dupont, Sabrina Barchuk, Silvina Figurelli, Daniel Lopez Della Vecchia, Juan C Roa, Pablo Guzmán, Cecilia J Proietti, Roxana Schillaci, Patricia V Elizalde

  • Frontiers in Oncology

    22/04/2020

    Frontiers in Oncology

    Tumor Necrosis Factor ? Blockade: An Opportunity to Tackle Breast Cancer

    María Florencia Mercogliano, Sofía Bruni, Patricia V Elizalde, Roxana Schillaci

  • Biochimica et Biophysica Acta

    01/03/2020

    Steroids

    Steroid hormone receptors: a south american perspective

    Elizalde PV, Proietti CJ.

  • 29/01/2020

    Oncoimmunology

    Blockade of Stat3 oncogene addiction induces cellular senescence and reveals a cell-nonautonomous activity suitable for cancer immunotherapy

    De Martino M, Tkach M, Bruni S, Rocha D, Mercogliano MF, Cenciarini ME, Chervo MF, Proietti CJ, Dingli F, Loew D, Fernández EA, Elizalde PV, Piaggio E, Schillaci R.

  • Biochimica et Biophysica Acta

    01/12/2019

    Steroids

    Molecular mechanisms underlying progesterone receptor action in breast cancer: insights into cell proliferation and stem cell regulation

    Cenciarini ME, Proietti CJ.

  • 01/06/2019

    Hormones and Cancer

    Nuclear ErbB-2: a Novel Therapeutic Target in ErbB-2-Positive Breast Cancer?

    Cordo Russo RI, Chervo MF, Madera S, Charreau EH, Elizalde PV.